Published in The New England Journal of Medicine. Peer-reviewed. Large sample size. Sound methodology. An antiviral pill has, for the first time, been shown to prevent COVID-19 in individuals exposed to SARS-CoV-2. Ensitrelvir blocks the enzyme coronaviruses need to make new copies of themselves.
NIH T32 proposal with @joannamasel.bsky.social and @wheelerlab.org to renew the Computational and Mathematical Modeling in Biological Systems program for PhD students is funded, starting July 1! I look forward to supporting the next generation of quantitative biology researchers!
cmmbs.arizona.edu
One glimmer of hope in the Ebola response:
Within hours of the outbreak in DRC being declared, researchers convened to prepare drug trials.
A lot has changed on that front since the Ebola outbreak in West Africa a decade ago. But huge challenges remain 🧪
My story in @science.org (🧵 to come)
Drug arrives years after pandemic’s peak, but could still offer protection to vulnerable populations.
These are both long-term dangers. A shortage of standing genetic variation is more urgent than a shortage of new beneficial mutations, and a rise in inbreeding depression is more urgent than deleterious fixations. 3/5
